Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tamin Pharmaceutical Investment Company (TPICO) is the largest pharmaceutical holding group in Iran, controlling over 30% of the country's total pharmaceutical market. As a subsidiary of the Social Security Investment Company (SSIC), TPICO manages a diverse portfolio of more than 25 subsidiary companies involved in the entire value chain, including raw material production, finished dosage form manufacturing, and nationwide distribution. The group produces a wide range of products including small molecule generics, advanced biologics, oncology medications, and antibiotics. TPICO plays a critical role in Iran's healthcare infrastructure by ensuring the availability of essential medicines and pursuing export opportunities in regional markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iranian pharmaceutical companies.